Corpay Valuation

Is CPAY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CPAY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CPAY ($331) is trading below our estimate of fair value ($490.76)

Significantly Below Fair Value: CPAY is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CPAY?

Other financial metrics that can be useful for relative valuation.

CPAY key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue7.6x
Enterprise Value/EBITDA14.2x
PEG Ratio1.6x

Price to Earnings Ratio vs Peers

How does CPAY's PE Ratio compare to its peers?

The above table shows the PE ratio for CPAY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average37.1x
GPN Global Payments
17.8x10.4%US$25.1b
SQ Block
60.6x32.3%US$41.3b
JKHY Jack Henry & Associates
34.8x9.5%US$13.3b
WEX WEX
35.1x31.3%US$8.6b
CPAY Corpay
22.8x14.7%US$23.0b

Price-To-Earnings vs Peers: CPAY is good value based on its Price-To-Earnings Ratio (22.8x) compared to the peer average (37.1x).


Price to Earnings Ratio vs Industry

How does CPAY's PE Ratio compare vs other companies in the US Diversified Financial Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a1.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a1.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: CPAY is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the US Diversified Financial industry average (16x).


Price to Earnings Ratio vs Fair Ratio

What is CPAY's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CPAY PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.8x
Fair PE Ratio20.1x

Price-To-Earnings vs Fair Ratio: CPAY is expensive based on its Price-To-Earnings Ratio (22.8x) compared to the estimated Fair Price-To-Earnings Ratio (20.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CPAY forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$331.00
US$332.53
+0.5%
12.2%US$408.00US$265.00n/a15
Sep ’25US$315.55
US$322.00
+2.0%
9.9%US$376.00US$265.00n/a16
Aug ’25US$284.90
US$325.00
+14.1%
9.0%US$376.00US$265.00n/a17
Jul ’25US$266.26
US$321.12
+20.6%
9.5%US$376.00US$265.00n/a17
Jun ’25US$267.67
US$326.81
+22.1%
9.1%US$376.00US$265.00n/a16
May ’25US$296.25
US$328.93
+11.0%
9.8%US$376.00US$265.00n/a16
Apr ’25US$305.90
US$321.11
+5.0%
9.1%US$355.00US$255.00n/a16
Mar ’25US$276.60
US$316.34
+14.4%
7.8%US$343.00US$255.00n/a17
Feb ’25US$294.55
US$305.54
+3.7%
9.9%US$343.00US$240.00n/a17
Jan ’25US$282.61
US$291.18
+3.0%
8.8%US$343.00US$235.00n/a17
Dec ’24US$251.63
US$285.19
+13.3%
7.7%US$315.00US$235.00n/a16
Nov ’24US$228.60
US$292.13
+27.8%
8.0%US$326.00US$244.00n/a16
Oct ’24US$255.34
US$290.87
+13.9%
8.3%US$326.00US$244.00US$314.8515
Sep ’24US$272.86
US$286.37
+5.0%
8.1%US$326.00US$244.00US$315.5516
Aug ’24US$251.06
US$269.62
+7.4%
9.2%US$310.00US$230.00US$284.9016
Jul ’24US$251.08
US$252.93
+0.7%
6.2%US$300.00US$230.00US$266.2615
Jun ’24US$228.00
US$248.31
+8.9%
5.9%US$270.00US$207.00US$267.6716
May ’24US$213.89
US$242.66
+13.4%
5.7%US$260.00US$205.00US$296.2516
Apr ’24US$210.85
US$242.30
+14.9%
6.0%US$270.00US$205.00US$305.9016
Mar ’24US$213.50
US$241.52
+13.1%
6.1%US$270.00US$205.00US$276.6015
Feb ’24US$214.38
US$232.85
+8.6%
7.0%US$260.00US$188.00US$294.5515
Jan ’24US$183.68
US$228.12
+24.2%
8.3%US$266.00US$188.00US$282.6115
Dec ’23US$196.28
US$227.36
+15.8%
8.5%US$266.00US$188.00US$251.6314
Nov ’23US$186.64
US$242.21
+29.8%
13.4%US$312.00US$196.00US$228.6014
Oct ’23US$176.17
US$275.93
+56.6%
12.1%US$345.00US$220.00US$255.3414

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies